|
End-of-day quote
Shenzhen S.E.
2026-09-01
|
5-day change | 1st Jan Change | ||
| 6.410 CNY | +1.26% |
|
+3.55% | +2.23% |
| Market Cap | 2.98B 443M 382M 360M 328M 616M 42.06B 619M 4.25B 1.65B 21.39B 1.66B 1.63B 70.94B | P/E 2024 |
17.7x | P/E 2025 | 29.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.68B 547M 472M 444M 405M 761M 51.95B 765M 5.25B 2.04B 26.43B 2.06B 2.01B 87.62B | EV / Sales 2024 |
0.84x | EV / Sales 2025 | 0.94x |
| Free-Float |
64.76% | Yield 2024 |
1.63% | Yield 2025 | 1.59% |
| 1 day | +1.26% | ||
| 1 week | +3.55% | ||
| Current month | +1.26% | ||
| 1 month | +17.40% | ||
| 3 months | +9.76% | ||
| 6 months | -5.32% | ||
| Current year | +2.23% |
| 1 week | 6.26 |  | 6.59 |
| 1 month | 5.43 | | 7.35 |
| Current year | 4.95 | | 7.35 |
| 1 year | 4.95 | | 7.35 |
| 3 years | 4.26 | | 8.08 |
| 5 years | 4.26 | | 12.13 |
| 10 years | 3.4 | | 12.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tian Le Ru
CEO | Chief Executive Officer | 41 | 2022-07-06 |
Jun Li
DFI | Director of Finance/CFO | 49 | 2017-03-15 |
Qun Shan Zhang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Zhen Hong Lu
BRD | Director/Board Member | 51 | 2016-03-27 |
Tian Le Ru
BRD | Director/Board Member | 41 | 2022-07-06 |
Jin Chao Duan
BRD | Director/Board Member | 43 | 2022-07-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.26% | +3.55% | -5.87% | -1.92% | 443M | |
| +0.28% | -5.97% | +58.34% | +108.22% | 1,034B | |
| +2.01% | -0.71% | +53.07% | +68.99% | 654B | |
| +1.39% | -2.18% | +23.57% | +75.43% | 459B | |
| +0.82% | -4.83% | +33.78% | +36.04% | 343B | |
| -0.63% | +2.42% | +28.72% | +46.31% | 307B | |
| -0.43% | -2.62% | +0.08% | +11.45% | 251B | |
| +1.92% | -0.93% | +52.28% | +70.67% | 237B | |
| +0.54% | -3.10% | -17.56% | -54.91% | 202B | |
| +2.45% | +0.77% | +32.71% | +95.59% | 186B | |
| Average | +1.10% | -2.40% | +25.91% | +45.59% | 367.2B | |
| Weighted average by Cap. | +1.26% | -3.31% | +38.44% | +66.58% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.28B 637M 550M 517M 471M 886M 60.5B 891M 6.11B 2.38B 30.77B 2.39B 2.34B 102B | 3.86B 574M 495M 466M 424M 798M 54.48B 802M 5.51B 2.14B 27.71B 2.16B 2.11B 91.89B |
| Net income | 161M 23.93M 20.64M 19.42M 17.69M 33.26M 2.27B 33.44M 230M 89.34M 1.16B 89.84M 87.89M 3.83B | 99.42M 14.79M 12.76M 12M 10.93M 20.56M 1.4B 20.67M 142M 55.22M 714M 55.53M 54.33M 2.37B |
| Net Debt | 734M 109M 94.18M 88.59M 80.71M 152M 10.36B 153M 1.05B 408M 5.27B 410M 401M 17.48B | 701M 104M 89.9M 84.57M 77.04M 145M 9.89B 146M 1B 389M 5.03B 391M 383M 16.68B |
Employees
4,278
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | CN¥6.410 | +1.26% | 11,515,000 |
| 26-08-31 | CN¥6.330 | -1.86% | 16,299,740 |
| 26-08-28 | CN¥6.450 | 0.00% | 20,271,120 |
| 26-08-27 | CN¥6.450 | +2.54% | 33,919,701 |
| 26-08-26 | CN¥6.290 | +1.62% | 32,484,560 |
- Stock Market
- Stocks
- 000153 Stock
Select your edition
All financial news and data tailored to specific country editions
